Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan
- 6 June 2008
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 23 (4), 849-857
- https://doi.org/10.1038/eye.2008.136
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ONE-YEAR SAFETY AND EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSIONRetina, 2006
- INTRAVITREAL TRIAMCINOLONE ACETONIDE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSIONRetina, 2006
- Macular oedema in central retinal vein occlusion treated with intravitreal triamcinoloneActa Ophthalmologica Scandinavica, 2006
- INTRAVITREAL TRIAMCINOLONE TREATMENT FOR MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION AND HEMIRETINAL VEIN OCCLUSIONRetina, 2005
- Intravitreal triamcinolone acetonide for the management of diabetic papillopathyAmerican Journal of Ophthalmology, 2004
- Branch retinal vein occlusion treated by intravitreal triamcinolone acetonideEye, 2004
- Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndromeAmerican Journal of Ophthalmology, 2004
- Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusionOphthalmology, 2001
- RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSIONRetina, 2001
- Vascular endothelial growth factor upregulation in human central retinal vein occlusion11The authors have no proprietary interest in any of the materials used in this study.Ophthalmology, 1998